Sedafer
Sedafer, licence 02246732: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Euro-Pharm International Canada Inc.
- NPN or DIN-HM
- 02246732
- Status
- Inactive licence
- Licence date
- 24 June 2008
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- DIN de transition
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine C: up to 200 mg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 180 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine C Source : Acide ascorbique | 200.0 mg | 200,000 µg |
Non-medicinal ingredients
Hydroxypropylméthylcellulose, Cellulose, microcristalline, Ponceau SX, Poly(éthylène glycol), Triacétine, Dihydrate dibasique de phosphate de calcium, Croscarmellose de sodium, Acide stéarique, Dioxyde de titane, Béhénate de glycéryle
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adolescentes | minimum: 9.0 Année(s) ; maximum: 13.0 Année(s) | 1.0 Comprimé | 1.0 Tous les jours |
| Adolescentes | minimum: 14.0 Année(s) ; maximum: 18.0 Année(s) | 1.0 Comprimé | 1.0 Tous les jours |
| Adultes | minimum: 19.0 Année(s) | 1.0 Comprimé | 1.0 Tous les jours |
Uses authorised in Canada
Vitamin/Mineral supplement. A factor in the maintenance of good health. Iron helps to form red blood cells and helps in their proper function; helps to prevent iron deficiency anemia. Folate helps to reduce the risk of neural tube defects when taken daily prior to becoming pregant and during early pregnancy; helps the body to metabolize proteins; helps to form red blood cells; helps to prevent folate deficiency. Vitamin C helps the body to metabolize fats and proteins; helps in the developemnt and maintenance of bones, teeth and gums; helps in connective tissue formation; helps in wound healing; is an antioxidant for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Keep out of reach of children. There is enough drug in this package to seriously harm a child.
- Contre-indications
Prescribing information is not available to physicians and pharmacists on request.
- Effets indésirables connus
Some people may experience constipation, diarrhea and/or vomiting.
Source
Official Health Canada record, licence 02246732
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.